<DOC>
	<DOC>NCT01711190</DOC>
	<brief_summary>The aim of this project: 1. Confirming the modification in corneal astigmatism after trabeculectomy with MMC and intracameral administration of bevacizumab. 2. Medium-term follow up (6 months) of the induced corneal astigmatism. 3. Investigating correlations between postoperative astigmatism, particularly with the postoperative IOP.</brief_summary>
	<brief_title>Astigmatism Post-trabeculectomy</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Astigmatism</mesh_term>
	<criteria>Primary open angle glaucoma Normal tension glaucoma Pseudoexfoliation glaucoma Pigment dispersion glaucoma Patients who refuse to sign the informed consent. Patients with primary angle closure glaucoma (PACG). Patients younger than 18 years old. Other ocular diseases besides glaucoma. Significant corneal opacities. Refractive error more than + or 6.00 diopters. Visual acuity less than 0.05 Previous intraocular surgery (except cataract surgery more than six months preceding the trabeculectomy). Laser treatment for glaucoma within 6 months of the surgery.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>glaucoma</keyword>
	<keyword>trabeculectomy</keyword>
	<keyword>astigmatism</keyword>
	<keyword>intraocular pressure</keyword>
</DOC>